The primary objective of this clinical trial is to evaluate whether primary totalpancreatectomy with simultaneous islet autotransplantation compared with pancreatic headresection (alone) can reduce perioperative morbidity and time to initiation of adjuvanttherapy in patients with a high-risk constellation for pancreatic fistulas.
